Atrium Therapeutics, Inc. (RNA) Insider Trading

Name: Atrium Therapeutics, Inc. (RNA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 22, 2026): Younis Husam (Chief Scientific Officer): Tax Withholding of 11,216 shares, $100.4K.

Get alerted when insiders trade RNA

Email address

Loading company data...

Loading company details...